Breast cancer cells survive chemotherapy by activating targetable immune-modulatory programs characterized by PD-L1 or CD80.
Document Type
Article
Publication Date
12-1-2022
Publication Title
Nature cancer
First Page
1513
Last Page
1533
Volume
3
Issue
12
Publisher
Nature
Recommended Citation
Shahbandi, Ashkan; Chiu, Fang-Yen; Ungerleider, Nathan A.; Kvadas, Raegan; Mheidly, Zeinab; Sun, Meijuan J.S.; Tian, Di; Waizman, Daniel A.; Anderson, Ashlyn Y.; Machado, Healther L.; Pursell, Zachary F.; Rao, Sonia G.; and Jackson, James G., "Breast cancer cells survive chemotherapy by activating targetable immune-modulatory programs characterized by PD-L1 or CD80." (2022). School of Graduate Studies Faculty Publications. 397.
https://digitalscholar.lsuhsc.edu/sogs_facpubs/397
10.1038/s43018-022-00466-y
COinS